The Managed Ventricular pacing™ versus VVI 40 Pacing (MVP) Trial: Clinical background, rationale, design, and implementation

Journal of Cardiovascular Electrophysiology

Volumn 17, Issue 12, 2006, Pages 1295-1298

  Sweeney, Michael O ^a   Ellenbogen, Kenneth A ^b   Miller, Elaine Hogan ^c   Sherfesee, Lou ^c   Sheldon, Todd ^c   Whellan, David ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDTRONIC INC   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cardiac pacing; Heart failure; Implantable cardioverter defibrillators

Indexed keywords

ARTICLE; BRADYCARDIA; CANADA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; METHODOLOGY; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; UNITED STATES; WESTERN EUROPE;

CANADA; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EUROPE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; ISRAEL; MULTICENTER STUDIES; PROGNOSIS; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 33751342242     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2006.00656.x     Document Type: Article

References (23)

1. Sweeney MO, Ellenbogen KA, Betzold R, Sheldon T, Tang F, Lingle J, Mueller M: Multicenter, prospective, randomized trial of a new atrial-based Managed Ventricular Pacing Mode (MVP™) in dual chamber ICDs. J Cardiovasc Electrophysiol 2005;16:1-7.
2. Sweeney MO, Prinzen FW: A new paradigm for optimal ventricular pacing. J Am Coll Cardiol 2006;47:282-288.
3. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW: ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005;46:1116-1143.
4. Centers for Medicare and Medicaid Services: National coverage determination for implantable automatic defibrillators. In: Medicare coverage database. Effective January 27, 2005.
5. The Antiarrhythmics versus Implantable Defibrillator (AVID) Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.
6. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237.
7. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
8. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B, for the CIDS Investigators: Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302.
9. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber R, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL: ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American college of cardiology/American heart association task force on practice guidelines (ACC/AHA/NASPE committee to update the 1998 pacemaker guidelines). Circulation 2002;106:2145-2161.
10. Warman EN, Grammatico A, Padeletti L: Sample size estimates for atrial fibrillation endpoints. Heart Rhythm 2004;1:S58-S63.
11. Glotzer TV, Zimmerman J, Sweeney MO, Yee R, Marinchak RA, Cook J, Paraschos A, Love J, Radoslovich G, Hellkamp A, Lee KL, Lamas GA: Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: Report of the Atrial Diagnostics Ancillary Study of MOST. Circulation 2003;107:1614-1619.
12. Purerfellner H, Gillis AM, Holbrook R, Hettrick DA: Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies. Pacing Clin Electrophysiol 2004;27:983-992.
13. Ellenberg SS, Fleming TR, DeMets DL: Data Monitoring Committees in Clinical Trials: A Practical Perspective (Statistics in Practice). West Sussex, England: John Wiley & Sons; 2003:124-128.
14. The DAVID Trial Investigators: Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-3123.
15. Saul K, Diamond GA: Good enough: A primer on the analysis and interpretation of noninferiority trials. Ann Intern Med 2006;145:62-69.
16. Quesada A, Alemendral J, Arribas F, Ricci R, Walpert C, Adragao P, Cobo E, Navarro Z, on behalf DATAS investigators: DATAS: Dual Chamber & Atrial Tachyarrhythmias Adverse Event Study. In Cardiostim Late Breaking Clinical Trial. Nice, France; 2006.
17. Steinberg JS, Fischer A, Wang P, Schuger C, Daubert J, McNitt S, Andrews M, Brown M, Hall JW, Zareba W, Moss AJ: The clinical implications of cumulative right ventricular pacing in the Multicenter Automatic Defibrillator Trial II. J Cardiovasc Electrophysiol 2005;16:359-365.
18. Nielsen JC, Kristensen L, Andersen HR, Mortensen PT, Pedersen O, Pedersen AK: A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: Echocardiographic and clinical outcome. J Am Coll Cardiol 2003;42:614-623.
19. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA: Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;23:2932-2937.
20. Sweeney MO, Hellkamp AS: Heart failure during cardiac pacing. Circulation 2006;113:2082-2088.
21. Wyman BT, Hunter WC, Prinzen FW, Farris OP, McVeigh ER: Effects of single- and biventricular pacing on temporal and spatial dynamics of ventricular contraction. Am J Physiol 2002;282:H372-H379.
22. Yu Y, Kramer A, Spinelli J, Ding J, Hoersch W, Auricchio A: Biventricular mechanical asynchrony predicts hemodynamic effect of uni- and biventricular pacing. Am J Physiol Heart Circ Physiol 2003;285:H2788-H2796.
23. Goldberger Z, Elbel B, McPherson CA, Paltiel AD, Lampert R: Cost advantages of dual-chamber versus single-chamber cardioverter-defibrillator implantation. J Am Coll Cardiol 2005;46:850-857.